SCHEMBL4766907

SCHEMBL4766907

CCC(N)(CO)C(=O)Nc1ccc(-c2cccc(OCc3ccccc3)c2)cc1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
S1PR1 P21453 2/20 0.54
S1PR3 Q99500 2/20 0.54
S1PR4 O95977 1/20 0.54
S1PR5 Q9H228 1/20 0.54
PDK1 Q15118 1/20 0.53
PDK2 Q15119 1/20 0.53
PDK3 Q15120 1/20 0.53
PDK4 Q16654 1/20 0.53
NR1H4 Q96RI1 1/20 0.49
MRGPRX4 Q96LA9 2/20 0.49
HDAC4 P56524 1/20 0.48
DHODH Q02127 2/20 0.48
F10 P00742 3/20 0.47
SMPD1 P17405 1/20 0.47
NR4A2 P43354 1/20 0.46
RAB9A P51151 3/20 0.46
NPC1 O15118 2/20 0.46
LTA4H P09960 2/20 0.46
SMN1; SMN2 Q16637 2/20 0.46
CASP3 P42574 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4981969 0.88 S1PR1 (0.60) S1PR1S1PR3S1PR4S1PR5PDK1
SCHEMBL4981985 0.88 S1PR1 (0.60) S1PR1S1PR3S1PR4S1PR5PDK1
SCHEMBL14456427 0.78 LTA4H (0.60) NR1H4MRGPRX4HDAC4F10SMPD1
SCHEMBL4766898 0.77 LTA4H (0.50) NR1H4MRGPRX4HDAC4DHODHF10
SCHEMBL4979844 0.77 S1PR1 (0.74) S1PR1S1PR3S1PR4S1PR5RAB9A
SCHEMBL4979834 0.77 S1PR1 (0.74) S1PR1S1PR3S1PR4S1PR5RAB9A
SCHEMBL4983130 0.77 DHODH (0.54) S1PR1S1PR3S1PR4S1PR5DHODH
SCHEMBL4983141 0.77 DHODH (0.54) S1PR1S1PR3S1PR4S1PR5DHODH
SCHEMBL4983885 0.76 PDK1 (0.56) S1PR1S1PR3S1PR4S1PR5PDK1
SCHEMBL4983899 0.76 PDK1 (0.56) S1PR1S1PR3S1PR4S1PR5PDK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1981837-A2 METHODS AND COMPOSITIONS FOR MODULATING SPHINGOSINE-1-PHOSPHATE (S1P) RECEPTOR ACTIVITY Praecis Pharmaceuticals Incorporated (US) 2008-10-22 EP disclosed
WO-2007092190-A2 METHODS AND COMPOSITIONS FOR MODULATING SPHINGOSINE-1-PHOSPHATE (S1P) RECEPTOR ACTIVITY PRAECIS PHARMACEUTICALS, INC. (US) 2007-08-16 WO disclosed